| Ident. | Authors (with country if any) | Title |
|---|
| 002531 (2014) |
Waka Yokoyama [Japon] ; Kazuki Takada [Japon] ; Nobuyuki Miyasaka [Japon] ; Hitoshi Kohsaka [Japon] | Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis |
| 002834 (2013) |
Daniel E. Furst [États-Unis] ; Edward Clark Keystone [Canada] ; Alexander K. So [États-Unis, Canada, Allemagne, Pays-Bas, Italie, Royaume-Uni, Autriche] ; Jürgen Braun [Allemagne] ; Ferry C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Italie] ; Fabrizio De Benedetti [Allemagne] ; Thomas Dörner [Allemagne] ; Paul Emery [Royaume-Uni] ; Roy Fleischmann [États-Unis] ; Allan Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; Arthur Kavanaugh [États-Unis] ; Bruce Kirkham [Royaume-Uni] ; Philip Mease [États-Unis] ; A. Rubbert-Roth [Allemagne] ; Joachim Sieper [Allemagne] ; Nora G. Singer [États-Unis] ; Josef S. Smolen [Autriche] ; Piet L C M. Van Riel [Pays-Bas] ; Michael H. Weisman [États-Unis] ; Kevin L. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012 |
| 002854 (2013) |
Carrie L. Wagner [États-Unis] ; Sudha Visvanathan [États-Unis] ; Michael Elashoff [États-Unis] ; Iain B. Mcinnes [Royaume-Uni] ; Philip J. Mease [États-Unis] ; Gerald G. Krueger [États-Unis] ; Frederick T. Murphy [États-Unis] ; Kim Papp [Canada] ; Juan J. Gomez-Reino [Espagne] ; Michael Mack [États-Unis] ; Anna Beutler [Canada] ; Dafna Gladman [Canada] ; Arthur Kavanaugh [États-Unis] | Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab |
| 002866 (2013) |
Markku Hakala [Finlande] ; Kai Immonen [Finlande] ; Markku Korpela [Finlande] ; Mikko Vasala [Finlande] ; Markku J. Kauppi [Finlande] | Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis |
| 002868 (2013) |
Josef S. Smolen [Autriche] ; Daniel Aletaha [Autriche] | Forget personalised medicine and focus on abating disease activity |
| 002872 (2013) |
Daniel E. Furst [États-Unis] ; Roy Fleischman [États-Unis] ; Joachim Kalden [États-Unis] ; Arthur Kavanaugh [États-Unis] ; Joachim Sieper [États-Unis] ; Philip Mease [États-Unis] ; Josef Smolen [États-Unis] ; Ferrie Breedveld [États-Unis] | Documentation of off-label use of biologics in Rheumatoid Arthritis |
| 002874 (2013) |
Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] | Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions |
| 002875 (2013) |
Bente Glintborg [Danemark] ; Mikkel Stergaard [Danemark] ; Niels Steen Krogh [Danemark] ; Ulrik Tarp [Danemark] ; Natalia Manilo [Danemark] ; Anne Gitte Rasmussen Loft [Danemark] ; Annette Hansen [Danemark] ; Annette Schlemmer [Danemark] ; Victoria Fana [Danemark] ; Hanne M. Lindegaard [Danemark] ; Henrik Nordin [Danemark] ; Claus Rasmussen [Danemark] ; Leif Ejstrup [Danemark] ; Dorte Vendelbo Jensen [Danemark] ; Peter Mosborg Petersen [Danemark] ; Merete Lund Hetland [Danemark] | Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry |
| 002932 (2013) |
S. Sanchez [Espagne] ; S. Iniesta [Espagne] ; M. P. Lisbona [Espagne] ; A. Pàmies [Espagne] ; M. Almirall [Espagne] ; J. Maymo [Espagne] ; J. Carbonell [Espagne] | THU0461-HPR Global assessment of disease by the patient in the new ACR/EULAR remission criteria: Why do not fulfil the remission? |
| 002973 (2013) |
A. Kundzer ; I. Generalov [Biélorussie] ; M. Volkava [Biélorussie] ; D. Roggenbuck [Allemagne] ; P. Schierack [Allemagne] | THU0346 Dnase Activity of Polyclonal IgGs – A Putative Serological Marker in Patients with Spondyloarthritides |
| 002A91 (2013) |
S. G. Werner [Allemagne] ; F. Spiecker [Allemagne] ; S. Mettler [Allemagne] ; G. Lind-Albrecht [Allemagne] ; O. Wiemann [Allemagne] ; G. R. Burmester [Allemagne] ; M. Backhaus [Allemagne] ; H.-E. Langer [Allemagne] | SAT0526 ICG-Enhanced Fluorescence Optical Imaging (FOI) Detects Typical Inflammatory Changes in Subjects with Arthralgia and Psoriasis |
| 002A95 (2013) |
R. Osipyants [Russie] ; D. Karateev [Russie] ; E. Panasyuk [Russie] ; A. Smirnov [Russie] ; G. Lukina [Russie] ; S. Glukhova [Russie] ; E. Alexandrova [Russie] ; A. Volkov [Russie] ; E. Nasonov [Russie] | SAT0514 Associations between Functional Status and Ultrasound – Detected Synovitis and Joint Damage in Rheumatoid Arthritis during Tocilizumab Treatment |
| 002D01 (2013) |
J. Sieper [Allemagne] ; B. Porter-Brown [Royaume-Uni] ; L. Thompson [Royaume-Uni] ; O. Harari [Royaume-Uni] ; M. Dougados [France] | OP0166 Tocilizumab (TCZ) is not effective for the treatment of ankylosing spondylitis (AS): Results of a phase 2, international, multicentre, randomised, double-blind, placebo-controlled trial |
| 002D02 (2013) |
R. P. Poggenborg [Danemark] ; I. Eshed [Israël] ; S. J. Pedersen ; I. J. S Rensen [Danemark] ; O. R. Madsen ; J. M Ller [Danemark] ; M. Stergaard [Danemark] | OP0165 Whole-body MRI for assessment of enthesitis in psoriatic arthritis, axial spondyloarthritis and healthy subjects – a comparison with 7 clinical enthesitis indices |
| 002D03 (2013) |
K. De Vlam [Belgique] ; R. Lories [Belgique] | OP0164 Long-term TNF blockade induces joint repair in psoriatic arthritis |
| 002D49 (2013) |
Genevieve Tyra Ostring [Nouvelle-Zélande] ; Davinder Singh-Grewal [Australie] | Juvenile idiopathic arthritis in the new world of biologics |
| 002D72 (2013) |
R. Schiotis [Roumanie] ; P. Font ; A. Escudero ; A. Buzoianu [Roumanie] ; P. Zarco [Espagne] ; R. Almodovar [Espagne] ; J. Gratacos [Espagne] ; J. Mulero [Espagne] ; X. Juanola [Espagne] ; C. Montilla ; M. Moreno [Espagne] ; R. Ariza Ariza [Espagne] ; E. Collantes Estevez | FRI0417 Long term influence of nsaids on radiographic progression in patients with ankylosing spondylitis. |
| 002D73 (2013) |
C. Barnabe [Canada] ; N. X. Thanh ; A. Ohinmaa ; S. G. Barr [Canada] ; J. Homik [Canada] ; L. Martin [Canada] ; W. P. Maksymowych [Canada] | FRI0416 Remission definitions affect cost savings estimates in anti-TNF treated rheumatoid arthritis patients |
| 002D74 (2013) |
N. Nigil Haroon ; N. Alghanim ; R. D. Inman ; A. M. Cheung [Canada] | FRI0416 Effect of treatment with tumor necrosis factor inhibitors (TNFI) on bone mineral density (BMD) in patients with ankylosing spondylitis (AS) : a systematic review. |
| 002D75 (2013) |
M. Jani [Royaume-Uni] ; S. Moore [Royaume-Uni] ; H. Mirjafari [Royaume-Uni] ; E. Macphie ; C. Rao [Royaume-Uni] ; H. Chinoy [Royaume-Uni] ; Y. Mcloughlin [Royaume-Uni] ; P. Shah [Royaume-Uni] | FRI0415 Effectiveness of sequential biologic use in psoriatic arthritis: results of a large uk-based retrospective survey |
| 002D78 (2013) |
M. Zlnay ; D. Zlnay ; M. Salkova ; M. Oetterova [Slovaquie] ; D. Micekova ; K. Barancikova ; J. Rovensky ; I. Rybar | FRI0414 The risk of tuberculosis in patients with ankylosing spondylitis during anti-tnf therapy: data from national database in slovakia |
